Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Long-term management of leukocyte adhesion deficiency type III without hematopoietic stem cell transplantation.

Saultier P, Szepetowski S, Canault M, Falaise C, Poggi M, Suchon P, Barlogis V, Michel G, Loyau S, Jandrot-Perrus M, Bordet JC, Alessi MC, Chambost H.

Haematologica. 2018 Feb 22. pii: haematol.2017.186304. doi: 10.3324/haematol.2017.186304. [Epub ahead of print] No abstract available.

2.

Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors.

Mancuso ME, Fischer K, Santagostino E, Oldenburg J, Platokouki H, Königs C, Escuriola-Ettingshausen C, Rivard GE, Cid AR, Carcao M, Ljung R, Petrini P, Altisent C, Kenet G, Liesner R, Kurnik K, Auerswald G, Chambost H, Mäkipernaa A, Molinari AC, Williams M, van den Berg HM; European Pediatric Network for Haemophilia Management (PedNet) the REMAIN (REal life MAnagement of children with INhibitors) Study Group.

Thromb Haemost. 2017 Dec;117(12):2274-2282. doi: 10.1160/TH17-01-0059. Epub 2017 Dec 6.

PMID:
29212115
3.

Plasma 7-Hydroxymethotrexate Levels Versus Methotrexate to Predict Delayed Elimination in Children Receiving High-Dose Methotrexate.

Fabresse N, Devictor B, Pissier C, Chambost H, Lacarelle B, Michel G, Solas C.

Ther Drug Monit. 2018 Feb;40(1):76-83. doi: 10.1097/FTD.0000000000000445.

PMID:
29120974
4.

Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A.

Calvez T, Chambost H, d'Oiron R, Dalibard V, Demiguel V, Doncarli A, Gruel Y, Huguenin Y, Lutz P, Rothschild C, Vinciguerra C, Goudemand J; for FranceCoag Collaborators.

Haematologica. 2018 Jan;103(1):179-189. doi: 10.3324/haematol.2017.174706. Epub 2017 Oct 12.

5.

Hematopoietic stem cell transplantation for the treatment of leukocyte adhesion deficiency type III.

Saultier P, Alessi MC, Michel G, Chambost H.

Pediatr Neonatol. 2017 Dec;58(6):560-561. doi: 10.1016/j.pedneo.2017.07.006. Epub 2017 Jul 24. No abstract available.

6.

Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study.

Liesner RJ, Abashidze M, Aleinikova O, Altisent C, Belletrutti MJ, Borel-Derlon A, Carcao M, Chambost H, Chan AKC, Dubey L, Ducore J, Fouzia NA, Gattens M, Gruel Y, Guillet B, Kavardakova N, El Khorassani M, Klukowska A, Lambert T, Lohade S, Sigaud M, Turea V, Wu JKM, Vdovin V, Pavlova A, Jansen M, Belyanskaya L, Walter O, Knaub S, Neufeld EJ.

Haemophilia. 2018 Mar;24(2):211-220. doi: 10.1111/hae.13320. Epub 2017 Aug 16.

PMID:
28815880
7.

Molecular cytogenetic characterization of five F8 complex rearrangements: utility for haemophilia A genetic counselling.

Jourdy Y, Chatron N, Fretigny M, Carage ML, Chambost H, Claeyssens-Donadel S, Roussel-Robert V, Negrier C, Sanlaville D, Vinciguerra C.

Haemophilia. 2017 Jul;23(4):e316-e323. doi: 10.1111/hae.13218. Epub 2017 May 5.

PMID:
28475226
8.

Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study.

Ducassou S, Leverger G, Fernandes H, Chambost H, Bertrand Y, Armari-Alla C, Nelken B, Monpoux F, Guitton C, Leblanc T, Fisher A, Lejars O, Jeziorski E, Fouissac F, Lutz P, Pasquet M, Pellier I, Piguet C, Vic P, Bayart S, Marie-Cardine A, Michel M, Perel Y, Aladjidi N.

Br J Haematol. 2017 Jun;177(5):751-758. doi: 10.1111/bjh.14627. Epub 2017 Apr 26.

PMID:
28444729
9.

Safety and effectiveness of room temperature stable recombinant factor VIIa in patients with haemophilia A or B and inhibitors: Results of a multinational, prospective, observational study.

Kavakli K, Demartis F, Karimi M, Eshghi P, Neme D, Chambost H, Sommer L, Zak M, Benson G.

Haemophilia. 2017 Jul;23(4):575-582. doi: 10.1111/hae.13227. Epub 2017 Apr 24.

PMID:
28440004
10.

The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.

Berntorp E, Dargaud Y, Hart D, Lobet S, Mancuso ME, d'Oiron R, Perry D, Pollard D, van den Berg M, Blatný J, Chambost H, Doria AS, Holme PA, Kaczmarek R, Mantovani L, McLaughlin P, Nanayakkara L, Petrini P, Sannié T, Laane E, Maia R, Dettoraki A, Farrell A, Halimeh S, Raza S, Taylor S.

Eur J Haematol. 2017 Jan;98 Suppl 85:1-15. doi: 10.1111/ejh.12828.

PMID:
28101938
11.

Choice of factor VIII/IX regimen in adolescents and young adults with severe or moderately severe haemophilia. A French national observational study (ORTHem 15-25).

Meunier S, d'oiron R, Chambost H, Dolimier E, Guillet B; ORTHem 15-25 Study Group.

Thromb Res. 2017 Mar;151:17-22. doi: 10.1016/j.thromres.2016.12.023. Epub 2016 Dec 28.

12.

α1 -antitrypsin Pittsburgh and plasmin-mediated proteolysis.

Henneuse A, Suchon P, Chambost H, Morange PE, Frere C, Alessi MC.

J Thromb Haemost. 2016 Oct;14(10):2023-2026. doi: 10.1111/jth.13426. Epub 2016 Sep 2.

PMID:
27468101
13.

Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.

Joly BS, Stepanian A, Leblanc T, Hajage D, Chambost H, Harambat J, Fouyssac F, Guigonis V, Leverger G, Ulinski T, Kwon T, Loirat C, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies.

Lancet Haematol. 2016 Nov;3(11):e537-e546. doi: 10.1016/S2352-3026(16)30125-9. Epub 2016 Oct 3.

PMID:
27720178
14.

Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study.

Sirvent A, Auquier P, Oudin C, Bertrand Y, Bohrer S, Chastagner P, Poirée M, Kanold J, Thouvenin S, Perel Y, Plantaz D, Tabone MD, Yakouben K, Gandemer V, Lutz P, Sirvent N, Vercasson C, Berbis J, Chambost H, Leverger G, Baruchel A, Michel G.

Bone Marrow Transplant. 2017 Jan;52(1):80-87. doi: 10.1038/bmt.2016.205. Epub 2016 Sep 5.

PMID:
27595286
15.

Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trial.

Kenet G, Chambost H, Male C, Lambert T, Halimeh S, Chernova T, Mancuso ME, Curtin J, Voigt C, Li Y, Jacobs I, Santagostino E; PROLONG-9FP Investigator Study Group.

Thromb Haemost. 2016 Sep 27;116(4):659-68. doi: 10.1160/TH16-03-0179. Epub 2016 Sep 1.

16.

The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucémie de l'Enfant et de L'Adolescent Study.

Visentin S, Auquier P, Bertrand Y, Baruchel A, Tabone MD, Pochon C, Jubert C, Poirée M, Gandemer V, Sirvent A, Bonneau J, Paillard C, Freycon C, Kanold J, Villes V, Berbis J, Oudin C, Galambrun C, Pellier I, Plat G, Chambost H, Leverger G, Dalle JH, Michel G.

Biol Blood Marrow Transplant. 2016 Nov;22(11):2003-2010. doi: 10.1016/j.bbmt.2016.08.004. Epub 2016 Aug 10.

17.

Metabolic syndrome in long-term survivors of childhood acute leukemia treated without hematopoietic stem cell transplantation: an L.E.A. study.

Saultier P, Auquier P, Bertrand Y, Vercasson C, Oudin C, Contet A, Plantaz D, Poirée M, Ducassou S, Kanold J, Tabone MD, Dalle JH, Lutz P, Gandemer V, Sirvent N, Thouvenin S, Berbis J, Chambost H, Baruchel A, Leverger G, Michel G.

Haematologica. 2016 Dec;101(12):1603-1610. Epub 2016 Aug 11.

18.

Hysteresis-like binding of coagulation factors X/Xa to procoagulant activated platelets and phospholipids results from multistep association and membrane-dependent multimerization.

Podoplelova NA, Sveshnikova AN, Kurasawa JH, Sarafanov AG, Chambost H, Vasil'ev SA, Demina IA, Ataullakhanov FI, Alessi MC, Panteleev MA.

Biochim Biophys Acta. 2016 Jun;1858(6):1216-27. doi: 10.1016/j.bbamem.2016.02.008. Epub 2016 Feb 10. Review.

19.

Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort.

Aladjidi N, Fernandes H, Leblanc T, Vareliette A, Rieux-Laucat F, Bertrand Y, Chambost H, Pasquet M, Mazingue F, Guitton C, Pellier I, Roqueplan-Bellmann F, Armari-Alla C, Thomas C, Marie-Cardine A, Lejars O, Fouyssac F, Bayart S, Lutz P, Piguet C, Jeziorski E, Rohrlich P, Lemoine P, Bodet D, Paillard C, Couillault G, Millot F, Fischer A, Pérel Y, Leverger G.

Front Pediatr. 2015 Sep 29;3:79. doi: 10.3389/fped.2015.00079. eCollection 2015.

20.

Response: Confounding by indication is unlikely to explain the higher inhibitor incidence in boys treated with a recombinant FVIII product.

Calvez T, Chambost H, Lutz P, Rothschild C, Goudemand J.

Blood. 2015 Jun 11;125(24):3817-9. doi: 10.1182/blood-2015-02-622167. No abstract available.

21.

Accidental poisoning with 6-MP in a sibling of pediatric patient treated with maintenance chemotherapy.

Fernandez A, Gervoise-Boyer MJ, Chambost H, Coze C, Andre N.

J Pediatr Hematol Oncol. 2015 May;37(4):331-2. doi: 10.1097/MPH.0000000000000328. No abstract available.

PMID:
25815749
22.

EQOFIX: a combined economic and quality-of-life study of hemophilia B treatments in France.

Polack B, Calvez T, Chambost H, Rothschild C, Goudemand J, Claeyssens S, Borel-Derlon A, Bardoulat I, Maurel F, Woronoff-Lemsi MC; EQOFIX Study Group.

Transfusion. 2015 Jul;55(7):1787-97. doi: 10.1111/trf.13016. Epub 2015 Feb 5.

PMID:
25652955
23.

Late cardiomyopathy in childhood acute myeloid leukemia survivors: a study from the L.E.A. program.

Barlogis V, Auquier P, Bertrand Y, Chastagner P, Plantaz D, Poiree M, Kanold J, Berbis J, Oudin C, Vercasson C, Allouche M, Tabone MD, Thouvenin-Doulet S, Saumet L, Chambost H, Baruchel A, Leverger G, Michel G.

Haematologica. 2015 May;100(5):e186-9. doi: 10.3324/haematol.2014.116574. Epub 2015 Jan 23. No abstract available.

24.

Full but impaired activation of innate immunity effectors and virus-specific T cells during CMV and EBV disease following cord blood transplantation.

Farnault L, Gertner-Dardenne J, Gondois-Rey F, Michel G, Chambost H, Hirsch I, Olive D.

Bone Marrow Transplant. 2015 Mar;50(3):459-62. doi: 10.1038/bmt.2014.275. Epub 2015 Jan 19. No abstract available.

PMID:
25599160
25.

[Scurvy, an old disease still in the news: two case reports].

Pailhous S, Lamoureux S, Caietta E, Bosdure E, Chambost H, Chabrol B, Bresson V.

Arch Pediatr. 2015 Jan;22(1):63-5. doi: 10.1016/j.arcped.2014.10.003. Epub 2014 Nov 20. French.

PMID:
25455083
26.

Quality of life in minor siblings of childhood leukemia survivors, long-term after diagnosis: A LEA study (for Leucemies de l'Enfant et de l'Adolescent--childhood and adolescent leukemia).

Berbis J, Oudin C, Alessandrini M, Vercasson C, Barlogis V, Chambost H, Michel G, Auquier P.

Psychooncology. 2015 Jun;24(6):661-8. doi: 10.1002/pon.3709. Epub 2014 Oct 28.

PMID:
25350894
27.

[Platelet transfusion and immunization anti-Rh1: implication for immunoprophylaxis].

Chambost H.

Transfus Clin Biol. 2014 Nov;21(4-5):210-5. doi: 10.1016/j.tracli.2014.08.137. Epub 2014 Oct 2. French.

PMID:
25282489
28.

Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A.

Calvez T, Chambost H, Claeyssens-Donadel S, d'Oiron R, Goulet V, Guillet B, Héritier V, Milien V, Rothschild C, Roussel-Robert V, Vinciguerra C, Goudemand J; FranceCoag Network.

Blood. 2014 Nov 27;124(23):3398-408. doi: 10.1182/blood-2014-07-586347. Epub 2014 Sep 24.

29.

Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study.

Powell JS, Apte S, Chambost H, Hermans C, Jackson S, Josephson NC, Mahlangu JN, Ozelo MC, Peerlinck K, Pasi J, Perry D, Ragni MV, Wang X, Jiang H, Li S, Cristiano LM, Innes A, Nugent K, Brennan A, Luk A, Allen G, Pierce GF, Robinson B.

Br J Haematol. 2015 Jan;168(1):124-34. doi: 10.1111/bjh.13112. Epub 2014 Sep 11.

PMID:
25208598
30.

Health status and quality of life of long-term survivors of childhood acute leukemia: the impact of central nervous system irradiation.

Benadiba J, Michel G, Auquier P, Chastagner P, Kanold J, Poirée M, Plantaz D, Padovani L, Berbis J, Barlogis V, Contet A, Chambost H, Sirvent N.

J Pediatr Hematol Oncol. 2015 Mar;37(2):109-16. doi: 10.1097/MPH.0000000000000209.

PMID:
24936742
31.

Peripheral blood cells chimerism after unrelated cord blood transplantation in children: kinetics, predictive factors and impact on post-transplant outcome.

Elkaim E, Picard C, Galambrun C, Barlogis V, Loundou A, Curtillet C, Oudin C, Thuret I, Chambost H, Michel G.

Br J Haematol. 2014 Aug;166(4):557-65. doi: 10.1111/bjh.12918. Epub 2014 Apr 29.

PMID:
24779895
32.

Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study.

Bernard F, Auquier P, Herrmann I, Contet A, Poiree M, Demeocq F, Plantaz D, Galambrun C, Barlogis V, Berbis J, Garnier F, Sirvent N, Kanold J, Chastagner P, Chambost H, Michel G.

Bone Marrow Transplant. 2014 May;49(5):709-16. doi: 10.1038/bmt.2014.3. Epub 2014 Feb 17.

PMID:
24535128
33.

Prevalence and risk factors of cataract after chemotherapy with or without central nervous system irradiation for childhood acute lymphoblastic leukaemia: an LEA study.

Alloin AL, Barlogis V, Auquier P, Contet A, Poiree M, Demeocq F, Herrmann I, Villes V, Bertrand Y, Plantaz D, Kanold J, Chastagner P, Chambost H, Sirvent N, Michel G.

Br J Haematol. 2014 Jan;164(1):94-100. doi: 10.1111/bjh.12598. Epub 2013 Oct 14.

PMID:
24116693
34.

[Infantile visceral leishmaniasis, an etiology of easily curable hemophagocytic lymphohistiocytosis syndrome].

Visentin S, Baudesson de Chanville A, Loosveld M, Chambost H, Barlogis V.

Arch Pediatr. 2013 Nov;20(11):1225-9. doi: 10.1016/j.arcped.2013.08.003. Epub 2013 Sep 26. French.

PMID:
24076317
35.

Procoagulant platelets form an α-granule protein-covered "cap" on their surface that promotes their attachment to aggregates.

Abaeva AA, Canault M, Kotova YN, Obydennyy SI, Yakimenko AO, Podoplelova NA, Kolyadko VN, Chambost H, Mazurov AV, Ataullakhanov FI, Nurden AT, Alessi MC, Panteleev MA.

J Biol Chem. 2013 Oct 11;288(41):29621-32. doi: 10.1074/jbc.M113.474163. Epub 2013 Aug 30.

36.

Cancer detection and management in patients with haemophilia: a retrospective European multicentre study.

Biron-Andreani C, de Moerloose P, D'oiron R, Chambost H, Schved JF, Hermans C.

Haemophilia. 2014 Jan;20(1):78-82. doi: 10.1111/hae.12250. Epub 2013 Aug 6.

PMID:
23919383
37.

Clinical evidence implicating gamma-delta T cells in EBV control following cord blood transplantation.

Farnault L, Gertner-Dardenne J, Gondois-Rey F, Michel G, Chambost H, Hirsch I, Olive D.

Bone Marrow Transplant. 2013 Nov;48(11):1478-9. doi: 10.1038/bmt.2013.75. Epub 2013 Jul 8. No abstract available.

PMID:
23832093
38.

Management of cardiovascular disease in haemophilia.

Cayla G, Morange PE, Chambost H, Schved JF.

Thromb Res. 2013 Jul;132(1):8-14. doi: 10.1016/j.thromres.2013.05.007. Epub 2013 Jun 6. Review.

PMID:
23746627
39.

Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood.

Girard P, Auquier P, Barlogis V, Contet A, Poiree M, Demeocq F, Berbis J, Herrmann I, Villes V, Sirvent N, Kanold J, Chastagner P, Chambost H, Plantaz D, Michel G.

Haematologica. 2013 Jul;98(7):1089-97. doi: 10.3324/haematol.2012.081265. Epub 2013 May 3.

40.

A French cohort of childhood leukemia survivors: impact of hematopoietic stem cell transplantation on health status and quality of life.

Berbis J, Michel G, Chastagner P, Sirvent N, Demeocq F, Plantaz D, Barlogis V, Contet A, Poirée M, Kanold J, Galambrun C, Baumstarck K, Chambost H, Auquier P.

Biol Blood Marrow Transplant. 2013 Jul;19(7):1065-72. doi: 10.1016/j.bbmt.2013.04.015. Epub 2013 Apr 22.

41.

[Vitamin K deficiency bleeding: a case secondary to transient neonatal cholestasis].

Baudesson de Chanville A, Oudyi M, Bresson V, Bosdure E, Roquelaure B, Chambost H, Dubus JC.

Arch Pediatr. 2013 May;20(5):503-6. doi: 10.1016/j.arcped.2013.02.078. Epub 2013 Apr 6. French.

PMID:
23566582
42.

Real-world outcomes with recombinant factor VIIa treatment of acute bleeds in haemophilia patients with inhibitors: results from the international ONE registry.

Chambost H, Santagostino E, Laffan M, Kavakli K; ONE Registry Steering Committee on behalf of the investigators.

Haemophilia. 2013 Jul;19(4):571-7. doi: 10.1111/hae.12140. Epub 2013 Apr 5.

PMID:
23557542
43.

Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study.

Gouw SC, van den Berg HM, Fischer K, Auerswald G, Carcao M, Chalmers E, Chambost H, Kurnik K, Liesner R, Petrini P, Platokouki H, Altisent C, Oldenburg J, Nolan B, Garrido RP, Mancuso ME, Rafowicz A, Williams M, Clausen N, Middelburg RA, Ljung R, van der Bom JG; PedNet and Research of Determinants of INhibitor development (RODIN) Study Group.

Blood. 2013 May 16;121(20):4046-55. doi: 10.1182/blood-2012-09-457036. Epub 2013 Apr 3.

44.

Use of clinical practice guidelines on long-term prophylaxis in severe hemophilia in France: a retrospective audit.

Meunier S, Chambost H, Demiguel V, Doncarli A, Suzan F, Trossaërt M.

J Pediatr. 2013 Jun;162(6):1241-4, 1244.e1. doi: 10.1016/j.jpeds.2012.11.080. Epub 2013 Jan 17.

PMID:
23333129
45.

Persistence of natural killer cells with expansion of a hypofunctional CD56-CD16+KIR+NKG2C+ subset in a patient with atypical Janus kinase 3-deficient severe combined immunodeficiency.

Farnault L, Chambost H, Michel G, Thuret I, de Saint Basile G, Fischer A, Picard C, Picard C, Orlanducci F, Farnarier C, Moretta A, Olive D.

J Allergy Clin Immunol. 2013 Apr;131(4):1230-3, 1233.e1-2. doi: 10.1016/j.jaci.2012.08.047. Epub 2012 Oct 12. No abstract available.

PMID:
23069490
46.

Clinical, functional and genetic analysis of twenty-four patients with chronic granulomatous disease - identification of eight novel mutations in CYBB and NCF2 genes.

Martel C, Mollin M, Beaumel S, Brion JP, Coutton C, Satre V, Vieville G, Callanan M, Lefebvre C, Salmon A, Pagnier A, Plantaz D, Bost-Bru C, Eitenschenck L, Durieu I, Floret D, Galambrun C, Chambost H, Michel G, Stephan JL, Hermine O, Blanche S, Blot N, Rubié H, Pouessel G, Drillon-Haus S, Conrad B, Posfay-Barbe KM, Havlicekova Z, Voskresenky-Baricic T, Jadranka K, Arriazu MC, Garcia LA, Sfaihi L, Bordigoni P, Stasia MJ.

J Clin Immunol. 2012 Oct;32(5):942-58. doi: 10.1007/s10875-012-9698-8. Epub 2012 May 5. Erratum in: J Clin Immunol. 2012 Oct;32(5):959-60. Mansour, Lamia Sfaihi Ben [corrected to Sfaihi, Lamia].

PMID:
22562447
47.

Early recovery of immunity after cord-blood transplantation in children: qualitative features and impact of cytomegalovirus infection.

Farnault L, Chambost H, Zandotti C, Mallet F, Barlogis V, Galambrun C, Michel G, Olive D.

Acta Haematol. 2012;128(1):7-16. doi: 10.1159/000337039. Epub 2012 May 3.

PMID:
22555589
48.

Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities.

Le Meignen M, Auquier P, Barlogis V, Sirvent N, Contet A, Simeoni MC, Galambrun C, Poirée M, Chastagner P, Play B, Villes V, Berbis J, Chambost H, Bordigoni P, Michel G.

Blood. 2011 Aug 11;118(6):1481-9. doi: 10.1182/blood-2011-01-332866. Epub 2011 May 19.

49.

Successful allogeneic hematopoietic stem cell transplantation for DOCK8 deficiency.

Barlogis V, Galambrun C, Chambost H, Lamoureux-Toth S, Petit P, Stephan JL, Michel G, Fischer A, Picard C.

J Allergy Clin Immunol. 2011 Aug;128(2):420-22.e2. doi: 10.1016/j.jaci.2011.03.025. Epub 2011 May 4. No abstract available.

PMID:
21546070
50.

Prevalence and epitope specificity of non-neutralising antibodies in a large cohort of haemophilia A patients without inhibitors.

Lebreton A, Lapalud P, Chambost H, Biron-Andréani C, Morange PE, Combescure C, Marquès-Verdier A, Berger C, Schved JF, Granier C, Lavigne-Lissalde G.

Thromb Haemost. 2011 Jun;105(6):954-61. doi: 10.1160/TH10-10-0668. Epub 2011 Apr 7.

PMID:
21475776

Supplemental Content

Loading ...
Support Center